Connect your AI

Opus Genetics IRD Book value per share

Book value per share at other companies

AbbVieABBV

-$3.75-568%

MeiraGTx Holdings plcMGTX

-$0.72-271%

4D Molecular TherapeuticsFDMT

$6.64-21.2%

Opko HealthOPK

$1.59-18.7%

Kodiak Sciences IncKOD

$1.81-12.2%

Regeneron PharmaceuticalsREGN

$291.77+10.4%

Other financials

Income statement

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

Operating cash flow-$12.7M-41.5%

Valuation

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

total stockholders equity/weighted shares diluted=-$0.53

Based on the most recent quarter.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opus Genetics's book value per share?: Opus Genetics (IRD) reported book value per share of -$0.53 in Q1 2026.
How has Opus Genetics's book value per share changed year-over-year?: Opus Genetics's book value per share decreased by 452.4% year-over-year, from $0.15 to -$0.53.
What is the long-term trend for Opus Genetics's book value per share?: Over 5 years (2020 to 2025), Opus Genetics's book value per share has grown at a -38.9% compound annual growth rate (CAGR), from -$2.89 to $0.25.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.